BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 23486268)

  • 1. Tumor thickness in mesothelioma predicts differential response to neoadjuvant therapy and survival.
    Zhou N; Bell CS; Feldman HA; Haymaker CL; Hofstetter WL; Tsao AS; Mehran RJ; Rice DC; Sepesi B;
    J Thorac Cardiovasc Surg; 2023 Aug; 166(2):362-371.e9. PubMed ID: 36737380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiomics/Radiogenomics in Lung Cancer: Basic Principles and Initial Clinical Results.
    Anagnostopoulos AK; Gaitanis A; Gkiozos I; Athanasiadis EI; Chatziioannou SN; Syrigos KN; Thanos D; Chatziioannou AN; Papanikolaou N
    Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computed Tomography and Spirometry Can Predict Unresectability in Malignant Pleural Mesothelioma.
    Bellini A; Dell'Amore A; Giraudo C; Modugno A; Bernardinello N; Terzi S; Zambello G; Pasello G; Zuin A; Rea F
    J Clin Med; 2021 Sep; 10(19):. PubMed ID: 34640425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Quantitative Imaging for Predicting Response to Therapy: Techniques and Clinical Applications.
    Bera K; Velcheti V; Madabhushi A
    Am Soc Clin Oncol Educ Book; 2018 May; 38(38):1008-1018. PubMed ID: 30231314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in the Management of Malignant Pleural Mesothelioma in 2017.
    McCambridge AJ; Napolitano A; Mansfield AS; Fennell DA; Sekido Y; Nowak AK; Reungwetwattana T; Mao W; Pass HI; Carbone M; Yang H; Peikert T
    J Thorac Oncol; 2018 May; 13(5):606-623. PubMed ID: 29524617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical diagnosis of malignant pleural mesothelioma.
    Bianco A; Valente T; De Rimini ML; Sica G; Fiorelli A
    J Thorac Dis; 2018 Jan; 10(Suppl 2):S253-S261. PubMed ID: 29507793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline.
    Kindler HL; Ismaila N; Armato SG; Bueno R; Hesdorffer M; Jahan T; Jones CM; Miettinen M; Pass H; Rimner A; Rusch V; Sterman D; Thomas A; Hassan R
    J Clin Oncol; 2018 May; 36(13):1343-1373. PubMed ID: 29346042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volumetric assessment in malignant pleural mesothelioma.
    Murphy DJ; Gill RR
    Ann Transl Med; 2017 Jun; 5(11):241. PubMed ID: 28706909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computer-aided volumetric assessment of malignant pleural mesothelioma on CT using a random walk-based method.
    Chen M; Helm E; Joshi N; Gleeson F; Brady M
    Int J Comput Assist Radiol Surg; 2017 Apr; 12(4):529-538. PubMed ID: 28028655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging in pleural mesothelioma: A review of the 13th International Conference of the International Mesothelioma Interest Group.
    Armato SG; Blyth KG; Keating JJ; Katz S; Tsim S; Coolen J; Gudmundsson E; Opitz I; Nowak AK
    Lung Cancer; 2016 Nov; 101():48-58. PubMed ID: 27794408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of response classification criteria for patients with malignant pleural mesothelioma.
    Labby ZE; Armato SG; Kindler HL; Dignam JJ; Hasani A; Nowak AK
    J Thorac Oncol; 2012 Nov; 7(11):1728-34. PubMed ID: 23059782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemotherapy of malignant pleural mesothelioma: have we made any progress?].
    Reck M; Heigener DF; Gatzemeier U
    Zentralbl Chir; 2008 Jun; 133(3):238-42. PubMed ID: 18563688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a systematic review and practice guideline.
    Ellis P; Davies AM; Evans WK; Haynes AE; Lloyd NS;
    J Thorac Oncol; 2006 Jul; 1(6):591-601. PubMed ID: 17409924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung volume measurements as a surrogate marker for patient response in malignant pleural mesothelioma.
    Labby ZE; Armato SG; Dignam JJ; Straus C; Kindler HL; Nowak AK
    J Thorac Oncol; 2013 Apr; 8(4):478-86. PubMed ID: 23486268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease volumes as a marker for patient response in malignant pleural mesothelioma.
    Labby ZE; Nowak AK; Dignam JJ; Straus C; Kindler HL; Armato SG
    Ann Oncol; 2013 Apr; 24(4):999-1005. PubMed ID: 23144443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of therapy responses and prediction of survival in malignant pleural mesothelioma through computer-aided volumetric measurement on computed tomography scans.
    Liu F; Zhao B; Krug LM; Ishill NM; Lim RC; Guo P; Gorski M; Flores R; Moskowitz CS; Rusch VW; Schwartz LH
    J Thorac Oncol; 2010 Jun; 5(6):879-84. PubMed ID: 20421814
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.